Indexé dans
- Ouvrir la porte J
- Clés académiques
- RechercheBible
- Infrastructure nationale des connaissances en Chine (CNKI)
- Centre international pour l'agriculture et les biosciences (CABI)
- RechercheRef
- Université Hamdard
- EBSCO AZ
- OCLC - WorldCat
- CABI texte intégral
- Publions
- Fondation genevoise pour la formation et la recherche médicales
- Google Scholar
Liens utiles
Partager cette page
Dépliant de journal
Revues en libre accès
- Agriculture et aquaculture
- Alimentation et nutrition
- Biochimie
- Bioinformatique et biologie des systèmes
- Business & Management
- Chimie
- Génétique et biologie moléculaire
- Immunologie & Microbiologie
- Ingénierie
- La science des matériaux
- Neurosciences & Psychologie
- Science générale
- Sciences cliniques
- Sciences environnementales
- Sciences médicales
- Sciences pharmaceutiques
- Sciences vétérinaires
- Soins infirmiers et soins de santé
Abstrait
Sickle Cell Disease (SCD) and COVID-19: Case Series
Awaji Q. Al-Naami, Liaqat A. Khan, Faisal I. Zaidan, Hussam M.Halawi, Laila E.Asiri, Taher A.Suamili, Amal A. Qaisi, Turki M.Darweesh, Ibrahim A Al-Naami
The ongoing pandemic of COVID-19 that started in the Hubei province of China in late December 2019, caused by severe acute respiratory syndrome corona virus-2 (SARS CoV-2). Globally millions affected by the disease so far. The risk of COVID-19 severity and its complications increases with age and other comorbidities. The course of SARS-CoV-2 infection or its related complications has yet to be established in patients with sickle cell disease (SCD), once more evidence is available. It is clear from the available data that the course of COVID-19 in patients with SCD is mild to moderate, seldom severe, and rarely fatal. Herein we report three known cases of SCD with confirmed COVID-19, in whom the course of the disease was mild to moderate and uncomplicated with uneventful recoveries.